The Effect of Garlic Tablet for Preventing Preterm Labor: A Randomized Clinical Trial

authors:

avatar Shirin Niroomanesh 1 , avatar Zeinab Shaker Ardakani ORCID 2 , * , avatar Mahboobeh Shirazi 3 , avatar Fedyeh Haghollahi ORCID 2 , avatar Mamak Shariat ORCID 3 , avatar Gholamreza Amin ORCID 4 , 5 , avatar MirFarbod Hojati Bagheri 2

Department of Obstetrics and Gynecology, Women's Hospital, Tehran University of Medical Sciences, Tehran, Iran
Vali-E-ASR Reproductive Health Research Center, Family Health Research Institute , Imam Khomeini Complex Hospital, Tehran, Iran
Maternal-Fetal and Neonatal Research Center, Family Health Research Institute, Tehran University of Medical Sciences, Tehran, Iran
Department of Pharmacognosy, Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
Department of Traditional Pharmacy, Traditional Medicine, Tehran University of Medical Sciences, Tehran, Iran

How To Cite Niroomanesh S, Shaker Ardakani Z, Shirazi M, Haghollahi F, Shariat M, et al. The Effect of Garlic Tablet for Preventing Preterm Labor: A Randomized Clinical Trial. Jundishapur J Nat Pharm Prod. 2023;18(3):e137008. https://doi.org/10.5812/jjnpp-137008.

Abstract

Background:

One of the important causes of neonatal mortality and morbidity is preterm birth. There is little evidence about the role of garlic in preventing preterm labor.

Objectives:

This study aimed to investigate the role of garlic tablets in preventing premature birth.

Methods:

This is a double-blind clinical trial. Five hundred and thirty-seven singleton pregnant women in the 16th to 26th week of pregnancy with a history of threatened preterm delivery (delivery before the 37th week of pregnancy) were included in this study. The participants were randomly divided into intervention (n = 272) and control groups (n = 265). The intervention group received garlic tablets (500 mg/day) every 24 hours for 10 weeks and 250 mg intramuscular progesterone every week until 36 weeks or delivery time. The control group received placebo tablets plus 250 mg intramuscular progesterone (every week until 36 weeks). The primary outcome was the incidence of Preterm delivery (gestational age < 37 weeks). Quantitative variables were expressed as frequency and percentage and compared using the chi-square or Fisher exact test with a small sample size. Numerical data were presented as mean and standard deviation. We used the Kolmogorov-Smirnov test to determine the normality of the data distribution. After that, the relationships of continuous variables with normal distribution were investigated using the independent t student test, and continuous variables without normal distribution were investigated with the non-parametric Mann-Whitney test. Multivariate logistic regression analysis estimated different variables' interaction and confounding effects.

Results:

Four hundred and forty-five had term delivery (82.9%), and 92 (17.1%) had preterm delivery. Seventeen participants in the intervention group (6.3%) and 75 (28.3%) in the control group had preterm delivery (P < 0.001). By considering preterm labor as dependent and other independent variables, the study group (intervention or control) was the only predictor of preterm labor (OR-3.6, CI: 95%: 1.98 - 6.5, P < 0.001).

Conclusions:

The results showed that the combined treatment of oral garlic tablets and intramuscular progesterone significantly prolonged pregnancy or improved outcomes. Garlic tablets seem to be effective in preventing preterm birth.

1. Background

Delivery before 37 weeks of gestation is considered preterm birth (PTB), accounting for 5 - 18% of pregnancies worldwide (1). PTB is associated with higher mortality and morbidity rates in neonates (2, 3). Nearly 4 million neonatal deaths occur annually, a quarter of which are due to premature birth (4) and in surviving preterm infants, chronic lung disease, growth delay, hearing impairment, respiratory distress syndrome, intraventricular hemorrhage, growth retardation, necrotizing enterocolitis, perforation, and retinopathy of prematurity are common (5). So, preventing preterm births is crucial and could be prevented with current, cost-effective interventions (6).

The evidence of the complex pathogenesis of preterm birth is still weak, which can explain the limitations of targeted and effective strategies to prevent it (1).

The causes of preterm birth are multifactorial (7). Infections and inflammation in the genital tract will increase PGE2 in amniotic fluid and trigger spontaneous preterm delivery (1, 7, 8).

Garlic has well-documented antimicrobial effects and contains enough dietary fiber (9). Garlic (Allium Sativum) has various compounds, including B vitamins, phosphorus, calcium, potassium, zinc, sulfur, and antioxidants. The sulfur compounds of garlic are the main reason for its pungent smell. Garlic has at least 33 sulfur compounds, such as allein, allicin, allyl propyl disulfide, aminoase enzymes, peroxidase, and 17 amino acids. One of the most important compounds of garlic is allicin (9, 10). Despite considerable effort, no one has detected allicin, alliin, or their metabolites in vivo or in human blood (11). Garlic stimulates selectively fermented compounds in the intestine, thereby balancing and activating the digestive microflora (10).

Previous studies have revealed the role of garlic as an antioxidant, hypotensive mediator, antimicrobial agent, and anti-diabetic drug (12-14).

2. Objectives

As there is little study on garlic's role in preventing preterm delivery, we designed this study to evaluate this garlic role.

3. Methods

The current study was a single-center, prospective, double-blind, randomized, placebo-controlled trial (RCT) conducted at Moheb Yas Hospital (an affiliated hospital of the Tehran University of Medical Sciences) between March 2015 and March 2016.

The Tehran University of Medical Sciences departmental ethics committee approved the research protocol with the number (IR.TUMS.REC.1395.2581). The IRCT registration number of this study is (IRCT 2017011824754N4).

The inclusion criteria were gestational age between 16 - 26 weeks, threatened preterm labor such as previous preterm delivery, surgery, cervical surgery, the history of abortion in the second trimester, bleeding during the first trimester, and multiparty.

Exclusion criteria were uterus anomalies, uterus myoma, mother age less than 18 or more than 40 years, anemia (HB less than 10), diabetes, hypertension, autoimmune diseases, fetal anomalies, preeclampsia, cerclage (cases with previous preterm labor underwent sonography and if they needed cerclage they were excluded).

All participants completed the informed consent form before entering the study. The study's method and the random use of garlic tablets or a placebo were explained to the participants. The authors declare that they have no conflicts of interest.

Randomization was done by an expert nurse via computer random number generation. Patients and physicians were blinded to the patient's group. A secretary gave tablets to the patients, who were blinded to the content of each tablet. Tablets were taken for 10 weeks (26 - 36 weeks). Enrolled cases followed up to delivery.

The enrolled pregnant women were randomly assigned to two groups:

Intervention group: Progesterone Amp (250 mg) + garlic tablet (500 mg)

Group: Progesterone Amp (250 mg) + placebo control

The garlic tablets contain powder (85.42%; equivalent to 8.9-mg allein) (Goldaroo Pharmaceutical Co., Isfahan, Iran). A 250 mg progesterone ampule (Proluton, Shafayab Gostar Company, Iran) was prescribed as an intramuscular injection. Garlic tablets were taken with a meal at the dose of one tablet every 24 hours for 10 weeks, and Progesterone ampule was taken once per week until 36 weeks.

The placebo tablets were produced in the same shape, color, and odor as the garlic tablets.

Patients were followed up regularly by phone calls to ensure adherence to the study protocol.

Also, participants were issued self-report forms to register daily complaints and record medicinal use to ensure the correct use of medication. Participants were reminded to attend the center or contact the researchers if they had problems. The occurrence of preterm birth was the primary outcome of the study (gestational age < 37 weeks).

The incidence of preterm premature rupture of membranes or obstetric complications (Chorio amnionitis, postpartum sepsis, and postpartum hemorrhage) was recorded. The side effects of the prescribed garlic tablets (such as dizziness, constipation, sleepiness, or vaginal dryness) were checked at least once in each of the second and third trimesters.

3.1. Statistical Analyses

Quantitative variables were expressed as frequency and percentage and compared using the chi-square or Fisher exact test with a small sample size. Numerical data were presented as mean and standard deviation. We used the Kolmogorov-Smirnov test to determine the data distribution normality. After that, the relationships of continuous variables with normal distribution were investigated using the independent t student test, and continuous variables without normal distribution were investigated with the non-parametric Mann-Whitney test. Multivariate logistic regression analysis was used to estimate different variables' interaction and confounding effects.

The distribution of variables in this study was normal except for Gravidity, Parity, live birth, and gestational age, which the Mann-Whitney test was used to assess instead of an independent t-test, and then the P-value was extracted. The significance level was considered 0.05 to interpret the relationships among the variables.

Multivariate-Binary regression analysis was used to investigate the true effect of some variables on the study outcome (occurrence of premature birth). It was used to estimate different variables' interaction and confounder effects on the outcome.

4. Results

From 630 participants, 30 were excluded from the study due to the need for cerclage. Due to a lack of consent, 28 women from the intervention group and 35 from the control group withdrew from the study. Thus, 537 pregnant women were randomized and started the study (Figure 1).

The consort flowchart
The consort flowchart

They were 272 in the intervention group and 265 in the control group. The two matched well for baseline characteristics (Table 1).

Table 1.

Evaluation of Demographic Variables (Qualitative and Quantitative) a,b,c,d

VariablesIntervention GroupControl GroupP-Value
Age (y)31.3 ± 5.231.4 ± 5.10.84*
Gestational age (week)23.25 ± 5.215.09 ± 6.20.0001+
Gravidity 2.4 ± 0.92.5 ± 1.70.10+
Parity 0.9 ± 0.71.2 ± 0.70.007+
Live birth 0.9 ± 0.71.1 ± 0.70.01+
History of abortion0.3 ± 0.70.5 ± 0.8s0.10+
NVD80 (29.4)49 (19.4)0.008**
C/S192 (70.6)204 (80.6)
Age less than 18 years1 (0.4)0 (0.0)0.3**
Age more than 40 years11 (4)12 (5.3)0.41**
Family history of preterm delivery4 (1.5)2 (0.9)0.52#
Previous abdominal surgery3 (1.1)0 (0.0)0.114#
High-risk occupation 3 (1.1)2 (0.9)0.812#
History of bleeding130 (47.8)48 (21.3)0.001**
Multiparity 187 (68.8)194 (86.2)0.001**
Uterus anomaly2 (0.7)1 (0.4)0.667#
Myoma4 (1.5)0 (0.0)0.068#
History of abortion in the second trimester0 (0.0)8 (3.6)0.002#
History of cervical surgery1 (0.4)2 (0.9)0.455#
History of anemia0 (0.0)5 (2.2)0.013#
History of diabetes1 (0.4)1 (0.4)0.893#
History of preterm delivery 6 (2.2)15 (6.7)0.014#

The participants were between 25 and 37 years old. Descriptive statistics in Table 1 show that the general characteristics of both groups were similar (P > 0.05).

The rates of C/S and history of preterm labor were statistically higher in the control group (Table 1).

No women developed diabetes or preeclampsia during pregnancy in both groups. The mean number of parity, live birth, and abortion significantly differed between the intervention and control groups (Table 1).

All participants were followed up until the labor time. Seventeen participants in the intervention group (6.3%) and 75 (28.3%) in the control group had preterm delivery (P < 0.001) (Table 2).

Table 2.

Preterm Outcomes in Two Groups a,b,c,d

VariablesIntervention Group (N = 265)Control Group (N = 272)P-Value
Preterm delivery17 (6.3)75 (28.3)0.001**
Cerclage 1 (0.4)1 (0.4)0.893#
Gestational age (week)36.25 ± 21.6039.57 ± 21.640.036+
Type of delivery0.329**
C/S182 (69.5)111 (74)
NVD80 (35.5)39 (26)
Newborn0.212**
Female111 (46)56 (39)
Male132 (54)87 (61)
Weight of neonate (gr)2702.77 ± 607.593273 ± 455.870.0001*

Multivariate-Binary regression analysis was used to estimate the interaction of different variables on outcome. Considering preterm labor as dependent and other variables (Multiparty, bleeding, anemia, intervention, and type of delivery) as independent variables, the study group (intervention or control) was the only predictor of preterm labor (OR-3.6, 95 %CI: 1.98 - 6.5, P < 0.001)

That is, preterm birth was reported in a higher percentage of participants in the control group (Table 2, 3). The two groups did not report Chorio amnionitis, postpartum sepsis, or hemorrhage.

Table 3.

Effects of Different Factors on Preterm Labor-A Logistic Regression Analysis a,b,c

VariablesBP-ValueAdjusted OR95% CI for Adj. OR
LowerUpper
Multiparity-0.0060.9890.9940.4152.383
Bleeding-0.3270.4170.7210.3271.589
Anemia-2.2660.0920.1040.0071.449
Group1.3050.00013.6861.8197.470
Delivery0.7730.0812.1660.9105.155
Constant0.1630.9561.177--

5. Discussion

The results of the current study revealed that garlic tablets could be beneficial in reducing preterm delivery. This study's total preterm delivery rate was 17%, consistent with the global estimate (preterm delivery between 5 - 18%) (15, 16).

Myhre et al. assessed the role of dried fruits and garlic pills on preterm labor and found that they are protective agents for preterm delivery [OR: 0.74 (95% CI: 0.65, 0.95)] (16). They argued that fruits containing antimicrobial or anti-inflammatory properties could reduce the risk of preterm labor.

According to regression analysis of the current study, the study group (intervention or control) was the only predictor of preterm labor (OR-3.6, CI95%: 1.98 - 6.5, P < 0.000), which could indicate the beneficial effect of consuming garlic peels for preterm labor prevention. Also, Myhre et al. found that probiotic consumption will reduce the risk of preterm delivery (17). Garlic with allicin has antibacterial properties against E. coli, S. aureus, E. faecalis, K. pneumonia, Candida spp., and T. vaginalis (18-22). Also, clinical evidence has revealed that oral garlic tablets can be as effective at treating Trichomonas vaginalis (23). This wide range of antimicrobial activity will decrease vaginal infection and reduce preterm labor (17). Garlic has antifungal activity against C. albicans, Candida, and Streptococcus mutants, which are responsible for preterm labor (18, 24).

Previous studies showed that women with bacterial vaginosis during pregnancy are at higher risk of preterm labor than those with normal vaginal flora (25). Administration of antibiotics such as garlic peels would help normalize vaginal flora and reduce preterm births. Preterm birth is one of the most common causes of neonatal death, and nearly 35% of neonatal deaths occur due to preterm labor (26-28). Therefore, according to the results of this study, it may be possible to point out the role of garlic tablets in preventing premature births.

The best strategy to study the role of garlic in preventing preterm birth is to target patients with recurrent spontaneous preterm labor. This was followed in the current study. Our findings can only be interpreted in high-risk women for preterm labor, and a high rate of our patients did continue their follow-up. The main power of this study is the large sample size and the prospective design. The limitations of this study; Failure to measure vaginal microbes and their changes with the use of garlic pills. Therefore, it is suggested to investigate these changes in future clinical trials. Also, studies are needed to improve methods of preterm birth prevention and facilitate effective health promotion strategies that include nutritional interventions during pregnancy or early pregnancy.

5.1. Conclusions

The study's results showed that the combined treatment significantly prolonged the pregnancy or improved its outcomes. Garlic tablets seem to be effective in preventing preterm birth.

Acknowledgements

References

  • 1.

    Green ES, Arck PC. Pathogenesis of preterm birth: Bidirectional inflammation in mother and fetus. Semin Immunopathol. 2020;42(4):413-29. [PubMed ID: 32894326]. [PubMed Central ID: PMC7508962]. https://doi.org/10.1007/s00281-020-00807-y.

  • 2.

    Samuel TM, Sakwinska O, Makinen K, Burdge GC, Godfrey KM, Silva-Zolezzi I. Preterm birth: A narrative review of the current evidence on nutritional and bioactive solutions for risk reduction. Nutrients. 2019;11(8). [PubMed ID: 31390765]. [PubMed Central ID: PMC6723114]. https://doi.org/10.3390/nu11081811.

  • 3.

    Wen SW, Smith G, Yang Q, Walker M. Epidemiology of preterm birth and neonatal outcome. Semin Fetal Neonatal Med. 2004;9(6):429-35. [PubMed ID: 15691780]. https://doi.org/10.1016/j.siny.2004.04.002.

  • 4.

    Mwansa-Kambafwile J, Cousens S, Hansen T, Lawn JE. Antenatal steroids in preterm labour for the prevention of neonatal deaths due to complications of preterm birth. Int J Epidemiol. 2010;39 Suppl 1(Suppl 1):i122-33. [PubMed ID: 20348115]. [PubMed Central ID: PMC2845868]. https://doi.org/10.1093/ije/dyq029.

  • 5.

    Ward RM, Beachy JC. Neonatal complications following preterm birth. An Int J Obst Gynaecology. 2003;110:8-16. https://doi.org/10.1046/j.1471-0528.2003.00012.x.

  • 6.

    World Health Organization. Preterm Birth. 2022. Available from: https://www.who.int/news-room/fact-sheets/detail/preterm-birth.

  • 7.

    Jiang M, Mishu MM, Lu D, Yin X. A case control study of risk factors and neonatal outcomes of preterm birth. Taiwan J Obstet Gynecol. 2018;57(6):814-8. [PubMed ID: 30545533]. https://doi.org/10.1016/j.tjog.2018.10.008.

  • 8.

    Romero R, Espinoza J, Goncalves LF, Kusanovic JP, Friel LA, Nien JK. Inflammation in preterm and term labour and delivery. Semin Fetal Neonatal Med. 2006;11(5):317-26. [PubMed ID: 16839830]. [PubMed Central ID: PMC8315239]. https://doi.org/10.1016/j.siny.2006.05.001.

  • 9.

    Yeganegi M, Watson CS, Martins A, Kim SO, Reid G, Challis JR, et al. Effect of Lactobacillus rhamnosus GR-1 supernatant and fetal sex on lipopolysaccharide-induced cytokine and prostaglandin-regulating enzymes in human placental trophoblast cells: Implications for treatment of bacterial vaginosis and prevention of preterm labor. Am J Obstet Gynecol. 2009;200(5):532 e1-8. [PubMed ID: 19285652]. https://doi.org/10.1016/j.ajog.2008.12.032.

  • 10.

    Kshirsagar MM, Dodamani AS, Karibasappa GN, Vishwakarma PK, Vathar JB, Sonawane KR, et al. Antibacterial activity of garlic extract on cariogenic bacteria: An in vitro study. Ayu. 2018;39(3):165-8. [PubMed ID: 31000994]. [PubMed Central ID: PMC6454914]. https://doi.org/10.4103/ayu.AYU_193_16.

  • 11.

    Kohlmeier M. Garlic compounds. Nutrient Metabolism. North Carolina, USA: Food Science and Technology; 2003. p. 106-9. https://doi.org/10.1016/b978-012417762-8.50026-0.

  • 12.

    Roberfroid MB. Inulin-type fructans: functional food ingredients. J Nutr. 2007;137(11 Suppl):2493S-502S. [PubMed ID: 17951492]. https://doi.org/10.1093/jn/137.11.2493S.

  • 13.

    Bayan L, Koulivand PH, Gorji A. Garlic: A review of potential therapeutic effects. Avicenna J phytomedicine. 2014;4(1):1.

  • 14.

    Colin-Gonzalez AL, Santana RA, Silva-Islas CA, Chanez-Cardenas ME, Santamaria A, Maldonado PD. The antioxidant mechanisms underlying the aged garlic extract- and S-allylcysteine-induced protection. Oxid Med Cell Longev. 2012;2012:907162. [PubMed ID: 22685624]. [PubMed Central ID: PMC3363007]. https://doi.org/10.1155/2012/907162.

  • 15.

    Thomson M, Al-Qattan KK, Js D, Ali M. Anti-diabetic and anti-oxidant potential of aged garlic extract (AGE) in streptozotocin-induced diabetic rats. BMC Complement Altern Med. 2016;16:17. [PubMed ID: 26786785]. [PubMed Central ID: PMC4719681]. https://doi.org/10.1186/s12906-016-0992-5.

  • 16.

    Myhre R, Brantsaeter AL, Myking S, Eggesbo M, Meltzer HM, Haugen M, et al. Intakes of garlic and dried fruits are associated with lower risk of spontaneous preterm delivery. J Nutr. 2013;143(7):1100-8. [PubMed ID: 23700347]. [PubMed Central ID: PMC3681545]. https://doi.org/10.3945/jn.112.173229.

  • 17.

    Myhre R, Brantsaeter AL, Myking S, Gjessing HK, Sengpiel V, Meltzer HM, et al. Intake of probiotic food and risk of spontaneous preterm delivery. Am J Clin Nutr. 2011;93(1):151-7. [PubMed ID: 20980489]. [PubMed Central ID: PMC3001603]. https://doi.org/10.3945/ajcn.110.004085.

  • 18.

    Abidullah M, Jadhav P, Sujan SS, Shrimanikandan AG, Reddy CR, Wasan RK. Potential antibacterial efficacy of garlic extract on staphylococcus aureus, escherichia coli, and klebsiella pneumoniae: An in vitro study. J Pharm Bioallied Sci. 2021;13(Suppl 1):S590-4. [PubMed ID: 34447159]. [PubMed Central ID: PMC8375933]. https://doi.org/10.4103/jpbs.JPBS_681_20.

  • 19.

    Dikasso D, Lemma H, Urga K, Debella A, Addis G, Tadele A, et al. Investigation on the antibacterial properties of garlic (Allium sativum) on pneumonia causing bacteria. Ethiopian Med J. 2002;40(3):241-9.

  • 20.

    Ruddock PS, Liao M, Foster BC, Lawson L, Arnason JT, Dillon JA. Garlic natural health products exhibit variable constituent levels and antimicrobial activity against neisseria gonorrhoeae, staphylococcus aureus and enterococcus faecalis. Phytother Res. 2005;19(4):327-34. [PubMed ID: 16041728]. https://doi.org/10.1002/ptr.1667.

  • 21.

    Ruiz R, Garcia MP, Lara A, Rubio LA. Garlic derivatives (PTS and PTS-O) differently affect the ecology of swine faecal microbiota in vitro. Vet Microbiol. 2010;144(1-2):110-7. [PubMed ID: 20080364]. https://doi.org/10.1016/j.vetmic.2009.12.025.

  • 22.

    Bahadoor S, Hadisa T, Shahrbanoo A, Elahm F, Mehrangiz A. In Vitro anti-Trichomonas activity of Freula assafoetida and garlic extracts. J Gorgan Univ Med Sci. 2009;11(3):17-3.

  • 23.

    Ibrahim AN. Comparison of in vitro activity of metronidazole and garlic-based product (Tomex(R)) on Trichomonas vaginalis. Parasitol Res. 2013;112(5):2063-7. [PubMed ID: 23455944]. https://doi.org/10.1007/s00436-013-3367-6.

  • 24.

    United Nations International Children's Emergency Fund; World Health Organization; World Bank Group; United Nations. Levels and trends in child mortality. New York; 2017. Available from: https://www.cabdirect.org/globalhealth/abstract/20183360422.

  • 25.

    Lamont RF. Infection in the prediction and antibiotics in the prevention of spontaneous preterm labour and preterm birth. An Int J Obst Gynaecology. 2003;110:71-5. https://doi.org/10.1046/j.1471-0528.2003.00034.x.

  • 26.

    Chawanpaiboon S, Vogel JP, Moller AB, Lumbiganon P, Petzold M, Hogan D, et al. Global, regional, and national estimates of levels of preterm birth in 2014: A systematic review and modelling analysis. Lancet Glob Health. 2019;7(1):e37-46. [PubMed ID: 30389451]. [PubMed Central ID: PMC6293055]. https://doi.org/10.1016/S2214-109X(18)30451-0.

  • 27.

    Luu TM, Katz SL, Leeson P, Thebaud B, Nuyt AM. Preterm birth: risk factor for early-onset chronic diseases. CMAJ. 2016;188(10):736-46. [PubMed ID: 26644500]. [PubMed Central ID: PMC4938684]. https://doi.org/10.1503/cmaj.150450.

  • 28.

    Halimi Asl AA, Safari S, Parvareshi Hamrah M. Epidemiology and Related Risk Factors of Preterm Labor as an obstetrics emergency. Emerg (Tehran). 2017;5(1). e3. [PubMed ID: 28286810]. [PubMed Central ID: PMC5325899].